Washington Biotechnology
  • In Vivo CRO Services
    • Autoimmune & Inflammatory Diseases
      • Multiple Sclerosis
      • Gout
      • Inflammatory Bowel Disease (IBD)
      • Dermatitis (Contact)
      • Lupus
      • Nephritis
      • Pancreatitis
      • Hepatitis
      • Psoriasis
      • Pulmonary Fibrosis
      • Diabetes
      • General Inflammation Assessment
      • Acute Choleostasis Model
    • Rheumatoid Arthritis
      • Collagen-Induced Arthritis Model
      • Adjuvant-Induced Arthritis Model
      • Carrageenan Air Pouch Model
      • Zymosan Air Pouch Model
      • Pristane-Induced Arthritis Model
      • Ovalbumin-Induced Arthritis Model
      • SCW PG-PS 10S Rat Model
      • Arthritis Combo Testing: Rodent/Rabbit
    • Cancer
      • WBI Cell Lines for Cancer Models
      • Xenograft, Orthotopic & Syngeneic Models
    • Bacterial Infection
      • MRSA Model
      • Listeria Model
    • Pain Studies
      • Formalin Test (Chemical Sensitivity)
    • Pharmacokinetics and Toxicity
      • Pharmacokinetics (PK)
      • Toxicity and MTD Studies
    • Support Services
      • In Vitro Compound Screening for Anti-inflammatory Activity
    • WBI Project Management
  • About Us
  • What's New
  • Contact Us
  • Sitemap
  • Careers
  • In Vivo CRO Services
    • Autoimmune & Inflammatory Diseases
      • Multiple Sclerosis
      • Gout
      • Inflammatory Bowel Disease (IBD)
      • Dermatitis (Contact)
      • Lupus
      • Nephritis
      • Pancreatitis
      • Hepatitis
      • Psoriasis
      • Pulmonary Fibrosis
      • Diabetes
        • STZ Rat Model
      • General Inflammation Assessment
      • Acute Choleostasis Model
    • Rheumatoid Arthritis
    • Cancer
    • Bacterial Infection
    • Pain Studies
    • Pharmacokinetics and Toxicity
    • Support Services
    • WBI Project Management
  • About Us
  • What's New
  • Contact Us
  • Sitemap
  • Careers

Diabetes

 

Diabetes mellitus or Type II Diabetes refers to a group of diseases that affect how the body uses blood glucose.​

Rats treated with the antibiotic Streptozocin provide our model for studying the effectiveness of potential anti-diabetic agents.

Diabetic condition in each rat is assessed by blood glucose measurements to select rats for the treatment of Test Materials. The treatment study parameters include urine collection studies with assay for albumin excreted in urine to provide a Urinary Albumin Excretion Rate (UAER). Ancillary measurements include glucose, ketones and blood in urine. We provide a statistical analysis of the UAER data in our Final Report along with the glucose and other measurements used to select diabetic rats for treatment.

Test materials are administered by injection, oral, or intratracheal administration. Plasma or sera are collected at designated time intervals for prompt shipment to your laboratory.

Our necropsy services include removal, weights, preservation and collection of designated organs for histology or shipment to your laboratory.

 

Contact Us
Request a Quote
What's New?
Read Our Newsletter

© Washington Biotechnology Inc., 2014. All Rights Reserved.
Built by Biz-Zone